Skip to main content
Top
Published in: Infection 5/2017

01-10-2017 | Images in Infection

Ocular and oto-syphilis: not a thing of the past

Authors: Chiara Papalini, Carlo Cagini, Giampietro Ricci, Maria Bruna Pasticci

Published in: Infection | Issue 5/2017

Login to get access

Excerpt

A 50-year-old male was admitted with mono-lateral visual deficit. Bilateral hearing loss and an elevated plaque type (Fig. 1a) lesion on his tongue had been present for 3 months. Clinical findings included hepato-splenomegaly and a light pink trunk macular rash. Left papillitis and vitreitis, visual acuity 4/10, plus bilateral sensorineural hearing deficit (Fig. 2a) were diagnosed. Abnormal laboratory tests evidenced: sedimentation rate of 41 mm for the first hour, C-reactive protein 1.5 mg/dL, aminotransferase 133 IU/L, gamma-glutamyltransferase 62 IU/L, Rapid Reaginic Test and Treponemal Pallidum Particle Agglutination positive: titer 1:32 and 1:5120, respectively, Fluorescent Treponemal Antibodies reactive, HBs antigen, HBc antibodies IgM and IgG positive. HIV and HCV antibodies tested both negative. The patient reported engaging in unsafe sex 5 months prior.
Literature
1.
go back to reference Eliott D, Papaliodis GN, Durand ML. Case 20–2016: a 50-year-old man with cloudy vision, hearing loss, and unsteadiness. New Engl J Med. 2016;374:2586–93.CrossRefPubMed Eliott D, Papaliodis GN, Durand ML. Case 20–2016: a 50-year-old man with cloudy vision, hearing loss, and unsteadiness. New Engl J Med. 2016;374:2586–93.CrossRefPubMed
2.
go back to reference De Goffau MJ, Doelman JC, van Rijswijk JB. Unilateral sudden hearing loss due to otosyphilis. Clin Pract. 2011;1:296–8.CrossRef De Goffau MJ, Doelman JC, van Rijswijk JB. Unilateral sudden hearing loss due to otosyphilis. Clin Pract. 2011;1:296–8.CrossRef
3.
go back to reference Woolston SL, Dhanireddy S, Marrazzo J. Ocular syphilis: a clinical review. Curr Infect Dis Rep. 2016;18:35–41.CrossRef Woolston SL, Dhanireddy S, Marrazzo J. Ocular syphilis: a clinical review. Curr Infect Dis Rep. 2016;18:35–41.CrossRef
4.
go back to reference De Paulo Barbosa LF, Servato SJP, Olivieira MTF, Durighetto AF Jr, Barbosa-Zanetta D. Oral manifestations of secondary syphilis. Intern J Infect Dis. 2015;35:40–2.CrossRef De Paulo Barbosa LF, Servato SJP, Olivieira MTF, Durighetto AF Jr, Barbosa-Zanetta D. Oral manifestations of secondary syphilis. Intern J Infect Dis. 2015;35:40–2.CrossRef
5.
go back to reference Little JW. Syphilis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:3–9.CrossRef Little JW. Syphilis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:3–9.CrossRef
7.
go back to reference Dos Santos TR, de Castro IJ, Dahia MM, de Azevedo MC, da Silva GA, Motta RN, da Cunha Pinto J, de Almeida Ferry FR. Malignant syphilis in an AIDS patient. Infection. 2015;43:231–6.CrossRefPubMed Dos Santos TR, de Castro IJ, Dahia MM, de Azevedo MC, da Silva GA, Motta RN, da Cunha Pinto J, de Almeida Ferry FR. Malignant syphilis in an AIDS patient. Infection. 2015;43:231–6.CrossRefPubMed
Metadata
Title
Ocular and oto-syphilis: not a thing of the past
Authors
Chiara Papalini
Carlo Cagini
Giampietro Ricci
Maria Bruna Pasticci
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1019-y

Other articles of this Issue 5/2017

Infection 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine